Core Viewpoint - Suzhou Chunqiu Electronics Technology Co., Ltd. has announced the cancellation of repurchased shares and a reduction in registered capital, which will not significantly impact the company's financial status or operations [2][10]. Group 1: Share Repurchase and Cancellation - The company held board meetings on December 2 and December 23, 2025, to approve the cancellation of 9,136,891 repurchased shares and the corresponding reduction in registered capital [2][7]. - Following the cancellation, the total share capital will decrease from 455,944,899 shares to 446,808,008 shares [2][10]. - The cancellation date for the repurchased shares is set for February 11, 2026 [3]. Group 2: Share Repurchase Plan and Implementation - The share repurchase plan was approved on May 5, 2022, with a total repurchase fund of no less than RMB 80 million and no more than RMB 150 million, at a maximum price of RMB 13.71 per share [5]. - As of February 20, 2023, the company had repurchased 9,136,891 shares, accounting for 2.0811% of the total share capital, with an average repurchase price of RMB 10.18 per share [5][6]. - The repurchased shares were intended for employee stock ownership plans or equity incentive plans [5]. Group 3: Legal and Regulatory Compliance - The cancellation of shares is in accordance with the Company Law of the People's Republic of China and relevant regulations regarding share repurchase [8][9]. - The company has notified creditors about the share cancellation, and no objections were raised within the stipulated period [9]. Group 4: Impact and Future Arrangements - The cancellation of repurchased shares will not adversely affect the company's financial condition or operational results, nor will it harm the interests of shareholders, especially minority investors [10]. - The company's control structure and compliance with listing requirements will remain unchanged following the share cancellation [10].

登录新浪财经APP 搜索【信披】查看更多考评等级 [重要提示] 1、南方中证港股通50交易型开放式指数证券投资基金联接基金（以下简称"本基金"）的发售已获中国 证监会2025年12月10日证监许可〔2025〕2745号文注册。 2、本基金是南方中证港股通50交易型开放式指数证券投资基金的ETF联接基金。 3、本基金的管理人和登记机构为南方基金管理股份有限公司（以下简称"本公司"），基金托管人为中 国工商银行股份有限公司。 4、本基金募集期自2026年3月9日至2026年3月20日，通过各销售机构的基金销售网点发售。 5、本基金的发售对象为符合法律法规规定的可投资于证券投资基金的个人投资者、机构投资者、合格 境外投资者以及法律法规或中国证监会允许购买证券投资基金的其他投资人。 6、本基金首次认购和追加认购最低金额均为人民币1元（含认购费，如有），具体认购金额以各基金销 售机构的公告为准。 7、有效认购款项在募集期间产生的利息将折算为基金份额归基金份额持有人所有，其中利息转份额的 数额以登记机构的记录为准。 8、基金投资人在募集期内可多次认购，认购一经确认不得撤销。基金销售机构对认购申请的受理并不 代表该申请一定 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000703 证券简称：恒逸石化 公告编号：2026-024 恒逸石化股份有限公司 关于召开2026年第二次临时股东会的提示性公告 本公司及董事会全体保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2026年第二次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市规则》《深圳证 券交易所上市公司自律监管指引第1号一一主板上市公司规范运作》等法律、行政法规、部门规章、规 范性文件及《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2026年02月25日14:30:00 6、会议的股权登记日：2026年02月10日 7、出席对象： （1）截至2026年2月10日下午收市时在中国证券登记结算有限责任公司深圳分公司登记在册的本公司全 体股东均有权出席股东会，并可以以书面形式委托代理人出席会议和参加表决，该股东代理人不必是本 公司股东。 （2）公司董事和高级管理人员； （2）网络投票时间：通过深圳证券交易所系统进行网络 ...

Core Viewpoint - In January 2026, Daqin Railway reported a cargo transportation volume of 31.28 million tons, reflecting a year-on-year growth of 5.00% [1] Group 1: Operational Performance - The average daily transportation volume reached 1.009 million tons [1] - The average number of heavy trains operated daily was 84.6 [1] - Among these, an average of 44.5 trains carrying 20,000 tons were operated daily [1] Group 2: Data Reliability - The operational data is sourced from the company's internal statistics and may vary monthly due to factors such as market conditions, equipment maintenance, and unloading capacity [1]

公司董事会对游通先生在本次发行项目期间所做的工作表示衷心的感谢！ 证券代码：603215 证券简称：比依股份 公告编号：2026-007 浙江比依电器股份有限公司 关于变更保荐代表人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 浙江比依电器股份有限公司（以下简称"公司"）于近日收到中信证券股份有限公司（以下简称"中信证 券"）出具的《关于更换保荐代表人的函》，具体情况如下：中信证券作为公司2024年度向特定对象发 行A股股票项目（以下简称"本次发行项目"）的保荐人，原委派唐青女士、游通先生担任保荐代表人负 责相关工作。原保荐代表人游通先生因工作变动原因不再负责相关工作，中信证券现委派何康先生接替 工作，担任公司本次发行项目的保荐代表人，继续履行尽职调查义务。此次变更后，公司2024年度向特 定对象发行A股股票项目的保荐代表人为唐青女士和何康先生。何康先生的简历详见附件。 本次保荐代表人更换后，公司2024年度向特定对象发行A股股票项目的保荐代表人为唐青女士和何康先 生。 特此公告。 浙江比依电器股份有限公司董事会 2 ...

证券代码：600151 证券简称：航天机电 公告编号：2026-004 上海航天汽车机电股份有限公司 关于召开2026年第一次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： (一)股东会类型和届次 2026年第一次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2026年2月26日 14点45分 召开地点：上海市元江路3883号一号楼 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2026年2月26日 至2026年2月26日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东会召开当日的交易时间 段，即9:15-9:25，9:30-11:30，13:00-15:00；通过互联网投票平台的投票时间为股东会召开当日的9:15- 15:00。 (六)融资融券、转融通、约定购回业务账户和沪股通投资者 ...

Core Viewpoint - The company has received a regulatory letter from the Shanghai Stock Exchange regarding its performance forecast and has provided detailed responses concerning its investment in Hangzhou Industrial Trust (杭工信) and the associated fair value losses [1][4]. Group 1: Investment in Hangzhou Industrial Trust - The company reported a significant fair value loss of approximately 94.4 million yuan related to its investment in Hangzhou Industrial Trust, with the investment amounting to 306 million yuan and a book value of 220 million yuan as of mid-2025 [1][4]. - The fair value losses for the years 2023 and 2024 were 11.32 million yuan and 37.43 million yuan, respectively [1]. - The company is required to disclose the financial and operational data of Hangzhou Industrial Trust for the past three years, including total assets, liabilities, net assets, operating income, and net profit [1]. Group 2: Fair Value Measurement and Losses - The company classifies its equity investment in Hangzhou Industrial Trust as a financial asset measured at fair value, with changes recognized in profit or loss [2][3]. - The fair value measurement methodology includes using market prices when available, or estimating based on the financial performance of the underlying assets when market prices are not available [3][14]. - The company confirmed that the significant fair value losses were due to substantial changes in Hangzhou Industrial Trust's financial condition, leading to continuous net losses and a decrease in net assets over the past three years [4][17]. Group 3: Financial Assets and Performance - As of the end of 2023, 2024, and mid-2025, the company's financial assets measured at fair value were valued at 1.526 billion yuan, 1.692 billion yuan, and 1.697 billion yuan, respectively, with corresponding fair value losses of -171 million yuan, 23.568 million yuan, and -3.8297 million yuan [5][17]. - The company has also reported its trading financial assets, non-current assets due within one year, and other non-current financial assets, with respective values of 1.229 billion yuan, 110 million yuan, and 358 million yuan as of mid-2025 [5]. Group 4: Long-term Equity Investments - The company's long-term equity investments were valued at 580 million yuan, 579 million yuan, and 584 million yuan at the end of 2023, 2024, and mid-2025, respectively [17][18]. - The company uses the equity method for accounting its long-term equity investments, reflecting its significant influence over the invested companies [18][22]. - The company has confirmed that there are no significant impairment risks associated with its long-term equity investments, as the underlying companies have shown stable operational performance [24][25].

Group 1 - Seedance2.0 is expected to be a pivotal moment for AI in the film industry, particularly in the production of AI comics and short dramas, leading to significant cost reductions and efficiency improvements in content creation [2] - The release of Seedance2.0 has sparked widespread evaluation and discussion within the industry, showcasing impressive capabilities in multi-modal thinking and video generation from various input types [2] - The film and television sector saw a substantial increase, with the film industry index rising by 13.83%, significantly outperforming other sectors, driven by the excitement around AI applications [2] Group 2 - The innovative pharmaceutical sector is experiencing a resurgence, with notable stock price increases among companies such as Wanbangde and Guangshengtang, indicating renewed investor interest [3] - The National Medical Products Administration announced that by 2025, China's pharmaceutical industry will accelerate its internationalization, with cumulative overseas licensing transactions for innovative drugs expected to exceed $130 billion [3] - A strategic cooperation agreement between Shiyao Group and AstraZeneca could yield up to $18.5 billion, marking a significant milestone in the company's business development transactions [3] Group 3 - Emerging technologies remain a key focus for the market, with a recommendation to concentrate on sectors benefiting from AI applications and international expansion [4] - The recent volatility in the Chinese stock market is attributed to global financial tightening concerns and pre-holiday cautious sentiment, but there is optimism regarding the domestic economic outlook [4] - The semiconductor sales growth is projected to accelerate, with high demand for domestic chips and related industries expected to continue through 2026 [4][5]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002567 证券简称：唐人神 公告编号：2026-011 唐人神集团股份有限公司 2026年1月生猪销售简报 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、生猪销售情况 二〇二六年二月十日 唐人神集团股份有限公司（以下简称"公司"）2026年1月生猪销量44.51万头（其中商品猪38.31万头，仔 猪6.20万头），2025年1月生猪销量45.91万头（其中商品猪43.41万头，仔猪2.5万头），同比下降 3.05%，环比下降10.01%；销售收入合计60,645万元，同比下降25.60%，环比下降3.29%。 上述数据未经审计，与定期报告披露的数据之间可能存在差异，因此上述数据仅作为阶段性数据供投资 者参考。 二、风险提示 （一）上述披露仅包含公司生猪养殖业务销售情况，不含饲料、肉品等业务情况。 （二）生猪市场价格波动的风险是整个生猪生产行业的系统风险，对任何一家生猪生产者来说，都是客 观存在的、不可控制的外部风险。生猪市场价格的大幅波动（下降或上升），都可能会对公司的经营业 绩产生较大影响 ...

Group 1 - The company held its 18th meeting of the 8th Board of Directors on February 10, 2026, with all 5 directors present, and the meeting complied with legal and regulatory requirements [2][4] - The Board approved the proposal to amend the Articles of Association, which includes adding one employee representative director to enhance corporate governance [2][10] - The independent director remuneration was adjusted from 60,000 RMB to 84,000 RMB per year, aiming to improve the motivation and responsibility of independent directors [4][18] Group 2 - The Board approved the proposal to dissolve the wholly-owned subsidiary Guangzhou Jialong Food Co., Ltd. and the Guangzhou branch to optimize resource allocation and reduce management costs [7][24] - The dissolution of these entities is expected to improve overall operational efficiency without adversely affecting the company's production and operations [28][25] Group 3 - The company announced the first extraordinary shareholders' meeting for 2026, scheduled for March 10, 2026, to discuss the approved proposals from the Board meeting [8][31] - The meeting will allow both on-site and online voting, with specific timeframes for each voting method [33][49]